We've found
4,882
archived clinical trials in
Obesity Weight Loss
We've found
4,882
archived clinical trials in
Obesity Weight Loss
The Effects of Including Almonds in a Weight Loss Trial
Updated: 1/16/2018
The Effects of Including Almonds in an Energy-restricted Diet on Weight, Abdominal Fat Loss, Blood Pressure, and Cognitive Function
Status: Enrolling
Updated: 1/16/2018
The Effects of Including Almonds in a Weight Loss Trial
Updated: 1/16/2018
The Effects of Including Almonds in an Energy-restricted Diet on Weight, Abdominal Fat Loss, Blood Pressure, and Cognitive Function
Status: Enrolling
Updated: 1/16/2018
Click here to add this to my saved trials
The Effects of Rimonabant, on Weight and Metabolic Risk Factors
Updated: 1/16/2018
The Effects of the Cannabinoid-1 Receptor Antagonist, Rimonabant, on Weight and Metabolic Risk Factors in People With Schizophrenia
Status: Enrolling
Updated: 1/16/2018
The Effects of Rimonabant, on Weight and Metabolic Risk Factors
Updated: 1/16/2018
The Effects of the Cannabinoid-1 Receptor Antagonist, Rimonabant, on Weight and Metabolic Risk Factors in People With Schizophrenia
Status: Enrolling
Updated: 1/16/2018
Click here to add this to my saved trials
The Effects of Rimonabant, on Weight and Metabolic Risk Factors
Updated: 1/16/2018
The Effects of the Cannabinoid-1 Receptor Antagonist, Rimonabant, on Weight and Metabolic Risk Factors in People With Schizophrenia
Status: Enrolling
Updated: 1/16/2018
The Effects of Rimonabant, on Weight and Metabolic Risk Factors
Updated: 1/16/2018
The Effects of the Cannabinoid-1 Receptor Antagonist, Rimonabant, on Weight and Metabolic Risk Factors in People With Schizophrenia
Status: Enrolling
Updated: 1/16/2018
Click here to add this to my saved trials
The Effects of Rimonabant, on Weight and Metabolic Risk Factors
Updated: 1/16/2018
The Effects of the Cannabinoid-1 Receptor Antagonist, Rimonabant, on Weight and Metabolic Risk Factors in People With Schizophrenia
Status: Enrolling
Updated: 1/16/2018
The Effects of Rimonabant, on Weight and Metabolic Risk Factors
Updated: 1/16/2018
The Effects of the Cannabinoid-1 Receptor Antagonist, Rimonabant, on Weight and Metabolic Risk Factors in People With Schizophrenia
Status: Enrolling
Updated: 1/16/2018
Click here to add this to my saved trials
The Effects of Rimonabant, on Weight and Metabolic Risk Factors
Updated: 1/16/2018
The Effects of the Cannabinoid-1 Receptor Antagonist, Rimonabant, on Weight and Metabolic Risk Factors in People With Schizophrenia
Status: Enrolling
Updated: 1/16/2018
The Effects of Rimonabant, on Weight and Metabolic Risk Factors
Updated: 1/16/2018
The Effects of the Cannabinoid-1 Receptor Antagonist, Rimonabant, on Weight and Metabolic Risk Factors in People With Schizophrenia
Status: Enrolling
Updated: 1/16/2018
Click here to add this to my saved trials
Efficacy of Vitamin D Supplementation in Bariatric Surgery Patients
Updated: 1/18/2018
Preoperative Vitamin D Status and Efficacy of Therapeutic Vitamin D Supplementation Postoperatively in Bariatric Surgery Patients
Status: Enrolling
Updated: 1/18/2018
Efficacy of Vitamin D Supplementation in Bariatric Surgery Patients
Updated: 1/18/2018
Preoperative Vitamin D Status and Efficacy of Therapeutic Vitamin D Supplementation Postoperatively in Bariatric Surgery Patients
Status: Enrolling
Updated: 1/18/2018
Click here to add this to my saved trials
Naltrexone for Antipsychotic-Induced Weight Gain
Updated: 1/19/2018
Naltrexone for Antipsychotic-Induced Weight Gain
Status: Enrolling
Updated: 1/19/2018
Naltrexone for Antipsychotic-Induced Weight Gain
Updated: 1/19/2018
Naltrexone for Antipsychotic-Induced Weight Gain
Status: Enrolling
Updated: 1/19/2018
Click here to add this to my saved trials
Effectiveness of Changing Dietary Fat on Weight Loss
Updated: 1/19/2018
A Comparison of A Hypocaloric Diet Plus One Hass Avocado Per Day Versus An Equally Hypocaloric Diet for Weight Loss, Satiety, Changes in Body Composition, and Risk Factors for Chronic Disease (HAWLS)
Status: Enrolling
Updated: 1/19/2018
Effectiveness of Changing Dietary Fat on Weight Loss
Updated: 1/19/2018
A Comparison of A Hypocaloric Diet Plus One Hass Avocado Per Day Versus An Equally Hypocaloric Diet for Weight Loss, Satiety, Changes in Body Composition, and Risk Factors for Chronic Disease (HAWLS)
Status: Enrolling
Updated: 1/19/2018
Click here to add this to my saved trials
Investigation on Safety, Tolerability and Pharmacokinetics of Single Doses of NNC0174-0833 in Normal Weight, Overweight to Obese But Otherwise Healthy Male Subjects
Updated: 1/23/2018
Investigation on Safety, Tolerability and Pharmacokinetics of Single Doses of NNC0174-0833 in Normal Weight, Overweight to Obese But Otherwise Healthy Male Subjects
Status: Enrolling
Updated: 1/23/2018
Investigation on Safety, Tolerability and Pharmacokinetics of Single Doses of NNC0174-0833 in Normal Weight, Overweight to Obese But Otherwise Healthy Male Subjects
Updated: 1/23/2018
Investigation on Safety, Tolerability and Pharmacokinetics of Single Doses of NNC0174-0833 in Normal Weight, Overweight to Obese But Otherwise Healthy Male Subjects
Status: Enrolling
Updated: 1/23/2018
Click here to add this to my saved trials
Improving Obesity Self-Care Among Mentally Ill Veterans
Updated: 1/24/2018
Improving Obesity Self-care Among Mentally Ill Veterans
Status: Enrolling
Updated: 1/24/2018
Improving Obesity Self-Care Among Mentally Ill Veterans
Updated: 1/24/2018
Improving Obesity Self-care Among Mentally Ill Veterans
Status: Enrolling
Updated: 1/24/2018
Click here to add this to my saved trials
Implementing Effective, Collaborative Care for Schizophrenia (EQUIP-2)
Updated: 1/24/2018
Implementing Effective, Collaborative Care for Schizophrenia
Status: Enrolling
Updated: 1/24/2018
Implementing Effective, Collaborative Care for Schizophrenia (EQUIP-2)
Updated: 1/24/2018
Implementing Effective, Collaborative Care for Schizophrenia
Status: Enrolling
Updated: 1/24/2018
Click here to add this to my saved trials
Implementing Effective, Collaborative Care for Schizophrenia (EQUIP-2)
Updated: 1/24/2018
Implementing Effective, Collaborative Care for Schizophrenia
Status: Enrolling
Updated: 1/24/2018
Implementing Effective, Collaborative Care for Schizophrenia (EQUIP-2)
Updated: 1/24/2018
Implementing Effective, Collaborative Care for Schizophrenia
Status: Enrolling
Updated: 1/24/2018
Click here to add this to my saved trials
Implementing Effective, Collaborative Care for Schizophrenia (EQUIP-2)
Updated: 1/24/2018
Implementing Effective, Collaborative Care for Schizophrenia
Status: Enrolling
Updated: 1/24/2018
Implementing Effective, Collaborative Care for Schizophrenia (EQUIP-2)
Updated: 1/24/2018
Implementing Effective, Collaborative Care for Schizophrenia
Status: Enrolling
Updated: 1/24/2018
Click here to add this to my saved trials
Implementing Effective, Collaborative Care for Schizophrenia (EQUIP-2)
Updated: 1/24/2018
Implementing Effective, Collaborative Care for Schizophrenia
Status: Enrolling
Updated: 1/24/2018
Implementing Effective, Collaborative Care for Schizophrenia (EQUIP-2)
Updated: 1/24/2018
Implementing Effective, Collaborative Care for Schizophrenia
Status: Enrolling
Updated: 1/24/2018
Click here to add this to my saved trials
Implementing Effective, Collaborative Care for Schizophrenia (EQUIP-2)
Updated: 1/24/2018
Implementing Effective, Collaborative Care for Schizophrenia
Status: Enrolling
Updated: 1/24/2018
Implementing Effective, Collaborative Care for Schizophrenia (EQUIP-2)
Updated: 1/24/2018
Implementing Effective, Collaborative Care for Schizophrenia
Status: Enrolling
Updated: 1/24/2018
Click here to add this to my saved trials
Implementing Effective, Collaborative Care for Schizophrenia (EQUIP-2)
Updated: 1/24/2018
Implementing Effective, Collaborative Care for Schizophrenia
Status: Enrolling
Updated: 1/24/2018
Implementing Effective, Collaborative Care for Schizophrenia (EQUIP-2)
Updated: 1/24/2018
Implementing Effective, Collaborative Care for Schizophrenia
Status: Enrolling
Updated: 1/24/2018
Click here to add this to my saved trials
Implementing Effective, Collaborative Care for Schizophrenia (EQUIP-2)
Updated: 1/24/2018
Implementing Effective, Collaborative Care for Schizophrenia
Status: Enrolling
Updated: 1/24/2018
Implementing Effective, Collaborative Care for Schizophrenia (EQUIP-2)
Updated: 1/24/2018
Implementing Effective, Collaborative Care for Schizophrenia
Status: Enrolling
Updated: 1/24/2018
Click here to add this to my saved trials
Implementing Effective, Collaborative Care for Schizophrenia (EQUIP-2)
Updated: 1/24/2018
Implementing Effective, Collaborative Care for Schizophrenia
Status: Enrolling
Updated: 1/24/2018
Implementing Effective, Collaborative Care for Schizophrenia (EQUIP-2)
Updated: 1/24/2018
Implementing Effective, Collaborative Care for Schizophrenia
Status: Enrolling
Updated: 1/24/2018
Click here to add this to my saved trials
Treatment of Overweight Induced by Antipsychotic Medication in Young People With Autism Spectrum Disorders (ASD)
Updated: 1/25/2018
Treatment of Overweight Induced by Antipsychotic Medication in Young People With Autism Spectrum Disorders (ASD)
Status: Enrolling
Updated: 1/25/2018
Treatment of Overweight Induced by Antipsychotic Medication in Young People With Autism Spectrum Disorders (ASD)
Updated: 1/25/2018
Treatment of Overweight Induced by Antipsychotic Medication in Young People With Autism Spectrum Disorders (ASD)
Status: Enrolling
Updated: 1/25/2018
Click here to add this to my saved trials
Treatment of Overweight Induced by Antipsychotic Medication in Young People With Autism Spectrum Disorders (ASD)
Updated: 1/25/2018
Treatment of Overweight Induced by Antipsychotic Medication in Young People With Autism Spectrum Disorders (ASD)
Status: Enrolling
Updated: 1/25/2018
Treatment of Overweight Induced by Antipsychotic Medication in Young People With Autism Spectrum Disorders (ASD)
Updated: 1/25/2018
Treatment of Overweight Induced by Antipsychotic Medication in Young People With Autism Spectrum Disorders (ASD)
Status: Enrolling
Updated: 1/25/2018
Click here to add this to my saved trials
Treatment of Overweight Induced by Antipsychotic Medication in Young People With Autism Spectrum Disorders (ASD)
Updated: 1/25/2018
Treatment of Overweight Induced by Antipsychotic Medication in Young People With Autism Spectrum Disorders (ASD)
Status: Enrolling
Updated: 1/25/2018
Treatment of Overweight Induced by Antipsychotic Medication in Young People With Autism Spectrum Disorders (ASD)
Updated: 1/25/2018
Treatment of Overweight Induced by Antipsychotic Medication in Young People With Autism Spectrum Disorders (ASD)
Status: Enrolling
Updated: 1/25/2018
Click here to add this to my saved trials
Treatment of Overweight Induced by Antipsychotic Medication in Young People With Autism Spectrum Disorders (ASD)
Updated: 1/25/2018
Treatment of Overweight Induced by Antipsychotic Medication in Young People With Autism Spectrum Disorders (ASD)
Status: Enrolling
Updated: 1/25/2018
Treatment of Overweight Induced by Antipsychotic Medication in Young People With Autism Spectrum Disorders (ASD)
Updated: 1/25/2018
Treatment of Overweight Induced by Antipsychotic Medication in Young People With Autism Spectrum Disorders (ASD)
Status: Enrolling
Updated: 1/25/2018
Click here to add this to my saved trials
Validation of Circulating Endothelial Cells and Microparticles in Youth
Updated: 1/30/2018
Validation of Circulating Endothelial Cells and Microparticles in Youth
Status: Enrolling
Updated: 1/30/2018
Validation of Circulating Endothelial Cells and Microparticles in Youth
Updated: 1/30/2018
Validation of Circulating Endothelial Cells and Microparticles in Youth
Status: Enrolling
Updated: 1/30/2018
Click here to add this to my saved trials
Energy Expenditure and Weight Loss Maintenance
Updated: 1/30/2018
Energy Expenditure in Subjects Successful at Weight Loss Maintenance
Status: Enrolling
Updated: 1/30/2018
Energy Expenditure and Weight Loss Maintenance
Updated: 1/30/2018
Energy Expenditure in Subjects Successful at Weight Loss Maintenance
Status: Enrolling
Updated: 1/30/2018
Click here to add this to my saved trials
Investigation of Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Multiple Dosing of NNC0174-0833 in Subjects With Obesity or Overweight
Updated: 1/31/2018
Investigation of Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Multiple Dosing of NNC0174-0833 in Subjects With Obesity or Overweight
Status: Enrolling
Updated: 1/31/2018
Investigation of Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Multiple Dosing of NNC0174-0833 in Subjects With Obesity or Overweight
Updated: 1/31/2018
Investigation of Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Multiple Dosing of NNC0174-0833 in Subjects With Obesity or Overweight
Status: Enrolling
Updated: 1/31/2018
Click here to add this to my saved trials
Weight Management in Obese Pregnant Underserved African American Women
Updated: 2/1/2018
Weight Management in Obese Pregnant Underserved African American Women
Status: Enrolling
Updated: 2/1/2018
Weight Management in Obese Pregnant Underserved African American Women
Updated: 2/1/2018
Weight Management in Obese Pregnant Underserved African American Women
Status: Enrolling
Updated: 2/1/2018
Click here to add this to my saved trials
Partners in Health: A Couples-based Approach to Obesity Prevention
Updated: 2/1/2018
Partners in Health: A Couples-based Approach to Obesity Prevention.
Status: Enrolling
Updated: 2/1/2018
Partners in Health: A Couples-based Approach to Obesity Prevention
Updated: 2/1/2018
Partners in Health: A Couples-based Approach to Obesity Prevention.
Status: Enrolling
Updated: 2/1/2018
Click here to add this to my saved trials
Chloroquine to Treat People With Metabolic Syndrome Aim2 (ARCH-MS)
Updated: 2/2/2018
Genotoxic Stress, Atherosclerosis, and Metabolic Syndrome-AIM 2
Status: Enrolling
Updated: 2/2/2018
Chloroquine to Treat People With Metabolic Syndrome Aim2 (ARCH-MS)
Updated: 2/2/2018
Genotoxic Stress, Atherosclerosis, and Metabolic Syndrome-AIM 2
Status: Enrolling
Updated: 2/2/2018
Click here to add this to my saved trials
Atheroma Reduction With Chloroquine in Patients With the Metabolic Syndrome (ARCH-MS)
Updated: 2/2/2018
Genotoxic Stress, Atherosclerosis, and Metabolic Syndrome- Aim 3
Status: Enrolling
Updated: 2/2/2018
Atheroma Reduction With Chloroquine in Patients With the Metabolic Syndrome (ARCH-MS)
Updated: 2/2/2018
Genotoxic Stress, Atherosclerosis, and Metabolic Syndrome- Aim 3
Status: Enrolling
Updated: 2/2/2018
Click here to add this to my saved trials
Muscle Lipid and Insulin Resistance in the Elderly
Updated: 2/3/2018
Muscle Lipid and Insulin Resistance in the Elderly
Status: Enrolling
Updated: 2/3/2018
Muscle Lipid and Insulin Resistance in the Elderly
Updated: 2/3/2018
Muscle Lipid and Insulin Resistance in the Elderly
Status: Enrolling
Updated: 2/3/2018
Click here to add this to my saved trials
Fatty Acid Radiotracer Comparison Study in Heart Failure Patients
Updated: 2/5/2018
Measurements of Myocardial Fatty Acid Metabolism With PET and [F-18]FluorbetaOx in Humans With Heart Failure With and Without Diabetes: Comparison With [C-11]Palmitate
Status: Enrolling
Updated: 2/5/2018
Fatty Acid Radiotracer Comparison Study in Heart Failure Patients
Updated: 2/5/2018
Measurements of Myocardial Fatty Acid Metabolism With PET and [F-18]FluorbetaOx in Humans With Heart Failure With and Without Diabetes: Comparison With [C-11]Palmitate
Status: Enrolling
Updated: 2/5/2018
Click here to add this to my saved trials
Framingham State Food Study
Updated: 2/6/2018
Dietary Composition and Energy Expenditure During Weight-Loss Maintenance
Status: Enrolling
Updated: 2/6/2018
Framingham State Food Study
Updated: 2/6/2018
Dietary Composition and Energy Expenditure During Weight-Loss Maintenance
Status: Enrolling
Updated: 2/6/2018
Click here to add this to my saved trials
Obalon Balloon System Pivotal IDE (SMART) Trial
Updated: 2/6/2018
The Six-Month Adjunctive Weight Reduction Therapy (SMART) Trial
Status: Enrolling
Updated: 2/6/2018
Obalon Balloon System Pivotal IDE (SMART) Trial
Updated: 2/6/2018
The Six-Month Adjunctive Weight Reduction Therapy (SMART) Trial
Status: Enrolling
Updated: 2/6/2018
Click here to add this to my saved trials
Obalon Balloon System Pivotal IDE (SMART) Trial
Updated: 2/6/2018
The Six-Month Adjunctive Weight Reduction Therapy (SMART) Trial
Status: Enrolling
Updated: 2/6/2018
Obalon Balloon System Pivotal IDE (SMART) Trial
Updated: 2/6/2018
The Six-Month Adjunctive Weight Reduction Therapy (SMART) Trial
Status: Enrolling
Updated: 2/6/2018
Click here to add this to my saved trials
Obalon Balloon System Pivotal IDE (SMART) Trial
Updated: 2/6/2018
The Six-Month Adjunctive Weight Reduction Therapy (SMART) Trial
Status: Enrolling
Updated: 2/6/2018
Obalon Balloon System Pivotal IDE (SMART) Trial
Updated: 2/6/2018
The Six-Month Adjunctive Weight Reduction Therapy (SMART) Trial
Status: Enrolling
Updated: 2/6/2018
Click here to add this to my saved trials
Obalon Balloon System Pivotal IDE (SMART) Trial
Updated: 2/6/2018
The Six-Month Adjunctive Weight Reduction Therapy (SMART) Trial
Status: Enrolling
Updated: 2/6/2018
Obalon Balloon System Pivotal IDE (SMART) Trial
Updated: 2/6/2018
The Six-Month Adjunctive Weight Reduction Therapy (SMART) Trial
Status: Enrolling
Updated: 2/6/2018
Click here to add this to my saved trials
Obalon Balloon System Pivotal IDE (SMART) Trial
Updated: 2/6/2018
The Six-Month Adjunctive Weight Reduction Therapy (SMART) Trial
Status: Enrolling
Updated: 2/6/2018
Obalon Balloon System Pivotal IDE (SMART) Trial
Updated: 2/6/2018
The Six-Month Adjunctive Weight Reduction Therapy (SMART) Trial
Status: Enrolling
Updated: 2/6/2018
Click here to add this to my saved trials
Obalon Balloon System Pivotal IDE (SMART) Trial
Updated: 2/6/2018
The Six-Month Adjunctive Weight Reduction Therapy (SMART) Trial
Status: Enrolling
Updated: 2/6/2018
Obalon Balloon System Pivotal IDE (SMART) Trial
Updated: 2/6/2018
The Six-Month Adjunctive Weight Reduction Therapy (SMART) Trial
Status: Enrolling
Updated: 2/6/2018
Click here to add this to my saved trials
Obalon Balloon System Pivotal IDE (SMART) Trial
Updated: 2/6/2018
The Six-Month Adjunctive Weight Reduction Therapy (SMART) Trial
Status: Enrolling
Updated: 2/6/2018
Obalon Balloon System Pivotal IDE (SMART) Trial
Updated: 2/6/2018
The Six-Month Adjunctive Weight Reduction Therapy (SMART) Trial
Status: Enrolling
Updated: 2/6/2018
Click here to add this to my saved trials
Obalon Balloon System Pivotal IDE (SMART) Trial
Updated: 2/6/2018
The Six-Month Adjunctive Weight Reduction Therapy (SMART) Trial
Status: Enrolling
Updated: 2/6/2018
Obalon Balloon System Pivotal IDE (SMART) Trial
Updated: 2/6/2018
The Six-Month Adjunctive Weight Reduction Therapy (SMART) Trial
Status: Enrolling
Updated: 2/6/2018
Click here to add this to my saved trials
Obalon Balloon System Pivotal IDE (SMART) Trial
Updated: 2/6/2018
The Six-Month Adjunctive Weight Reduction Therapy (SMART) Trial
Status: Enrolling
Updated: 2/6/2018
Obalon Balloon System Pivotal IDE (SMART) Trial
Updated: 2/6/2018
The Six-Month Adjunctive Weight Reduction Therapy (SMART) Trial
Status: Enrolling
Updated: 2/6/2018
Click here to add this to my saved trials
Obalon Balloon System Pivotal IDE (SMART) Trial
Updated: 2/6/2018
The Six-Month Adjunctive Weight Reduction Therapy (SMART) Trial
Status: Enrolling
Updated: 2/6/2018
Obalon Balloon System Pivotal IDE (SMART) Trial
Updated: 2/6/2018
The Six-Month Adjunctive Weight Reduction Therapy (SMART) Trial
Status: Enrolling
Updated: 2/6/2018
Click here to add this to my saved trials
Obalon Balloon System Pivotal IDE (SMART) Trial
Updated: 2/6/2018
The Six-Month Adjunctive Weight Reduction Therapy (SMART) Trial
Status: Enrolling
Updated: 2/6/2018
Obalon Balloon System Pivotal IDE (SMART) Trial
Updated: 2/6/2018
The Six-Month Adjunctive Weight Reduction Therapy (SMART) Trial
Status: Enrolling
Updated: 2/6/2018
Click here to add this to my saved trials
Obalon Balloon System Pivotal IDE (SMART) Trial
Updated: 2/6/2018
The Six-Month Adjunctive Weight Reduction Therapy (SMART) Trial
Status: Enrolling
Updated: 2/6/2018
Obalon Balloon System Pivotal IDE (SMART) Trial
Updated: 2/6/2018
The Six-Month Adjunctive Weight Reduction Therapy (SMART) Trial
Status: Enrolling
Updated: 2/6/2018
Click here to add this to my saved trials
Obalon Balloon System Pivotal IDE (SMART) Trial
Updated: 2/6/2018
The Six-Month Adjunctive Weight Reduction Therapy (SMART) Trial
Status: Enrolling
Updated: 2/6/2018
Obalon Balloon System Pivotal IDE (SMART) Trial
Updated: 2/6/2018
The Six-Month Adjunctive Weight Reduction Therapy (SMART) Trial
Status: Enrolling
Updated: 2/6/2018
Click here to add this to my saved trials
Obalon Balloon System Pivotal IDE (SMART) Trial
Updated: 2/6/2018
The Six-Month Adjunctive Weight Reduction Therapy (SMART) Trial
Status: Enrolling
Updated: 2/6/2018
Obalon Balloon System Pivotal IDE (SMART) Trial
Updated: 2/6/2018
The Six-Month Adjunctive Weight Reduction Therapy (SMART) Trial
Status: Enrolling
Updated: 2/6/2018
Click here to add this to my saved trials
Obalon Balloon System Pivotal IDE (SMART) Trial
Updated: 2/6/2018
The Six-Month Adjunctive Weight Reduction Therapy (SMART) Trial
Status: Enrolling
Updated: 2/6/2018
Obalon Balloon System Pivotal IDE (SMART) Trial
Updated: 2/6/2018
The Six-Month Adjunctive Weight Reduction Therapy (SMART) Trial
Status: Enrolling
Updated: 2/6/2018
Click here to add this to my saved trials
Web-based Weight Loss Intervention
Updated: 2/6/2018
Web-based Weight Loss Intervention
Status: Enrolling
Updated: 2/6/2018
Web-based Weight Loss Intervention
Updated: 2/6/2018
Web-based Weight Loss Intervention
Status: Enrolling
Updated: 2/6/2018
Click here to add this to my saved trials
Oxytocin Effects on Food Motivation Pathways
Updated: 2/7/2018
Oxytocin Effects on Food Motivation Pathways
Status: Enrolling
Updated: 2/7/2018
Oxytocin Effects on Food Motivation Pathways
Updated: 2/7/2018
Oxytocin Effects on Food Motivation Pathways
Status: Enrolling
Updated: 2/7/2018
Click here to add this to my saved trials
A Pharmacokinetic Study Comparing VI-0521 With Placebo in Obese Adolescents
Updated: 2/7/2018
A Randomized, Double-Blind, Placebo-Controlled, Pharmacokinetic and Pharmacodynamic Study of VI-0521 in Obese Adolescents
Status: Enrolling
Updated: 2/7/2018
A Pharmacokinetic Study Comparing VI-0521 With Placebo in Obese Adolescents
Updated: 2/7/2018
A Randomized, Double-Blind, Placebo-Controlled, Pharmacokinetic and Pharmacodynamic Study of VI-0521 in Obese Adolescents
Status: Enrolling
Updated: 2/7/2018
Click here to add this to my saved trials